[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Medicated Skin Care in Estonia

March 2012 | 23 pages | ID: MAE233F9B53EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Medicated skin care witnessed current value growth of 5% to reach EUR1.6 million in 2011 due to increased consumption. Consumers purchased medicated skin care products more freely in 2011 because of increased economic confidence increased as the average nominal wage rose. In addition, the news flow in media channels became more positive as many local companies posted very strong results compared to previous years and unemployment decreased as well. Due to many positive factors, consumers’...

Euromonitor International's Medicated Skin Care in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
MEDICATED SKIN CARE IN ESTONIA

Euromonitor International
March 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares 2008-2011
  Table 5 Hair Loss Treatments Brand Shares 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Walmark Spol Sro in Consumer Health (estonia)
Strategic Direction
Key Facts
  Summary 1 Walmark spol sro: Key Facts
  Summary 2 Walmark spol sro: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 3 Walmark spol sro: Competitive Position 2011
Executive Summary
Economy Shows Strong Signs of Recovery and Sales Increase
Health Organisations Try To Raise Consumer Awareness
International Players Strengthen Their Positions
Chemists/pharmacies Hold the Leading Position
Value Sales Expected To Record Steady Growth Over Forecast Period
Key Trends and Developments
Economic Conditions Help Drive Consumer Health Sales
Allowing OTC Medicines for Sale in Other Retailing Channels
Estonian Population Is Ageing
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 4 OTC Healthcare Switches 2009-2011
Sources
  Summary 5 Research Sources


More Publications